The artificial pancreas tested in France: what is it?


In Europe, 2 million people have type 1 diabetes, including 250,000 in France. The frequency of this autoimmune disease increases by an average of 5% every year. While World Diabetes Day took place on November 14, France 3 tells the story of three patients from the Perpignan hospital living with a completely autonomous artificial pancreas.

How does the artificial pancreas work?

The principle of the artificial pancreas is to mimic the action of the pancreas using an insulin pump and artificial intelligence. This device prevents the patient from personally measuring the blood glucose level to activate his insulin pump. It is intended for patients with type 1 diabetes. The benefit of the artificial pancreas has been validated by the HAS. Next step: the market launch scheduled for 2021. Meanwhile, it is being evaluated in France, only three patients live together.

How does it work ? They are equipped with a sensor that continuously measures the glucose level and adjusts the insulin level in real time, without the patient having to do anything. Everything communicates via bluetooth! The blood glucose data is sent to an artificial intelligence module, which instructs the pump to inject the correct dose of insulin. Connecting this tool to the Internet also allows the healthcare team to provide remote patient monitoring.

The only exception is (…)

Learn more at

DIRECT. Covid-19 in France on November 15: figures, announcements …
Do you know the technique to remove alcohol from the blood faster?
Covid-19: the R0 region by region
Tiredness: how to stop collapsing at the end of the day?
Consumers of organic products are less likely to have diabetes

Source link